These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
222 related items for PubMed ID: 29635788
1. Clinical findings and survival time in dogs with advanced heart failure. Beaumier A, Rush JE, Yang VK, Freeman LM. J Vet Intern Med; 2018 May; 32(3):944-950. PubMed ID: 29635788 [Abstract] [Full Text] [Related]
2. Survival and echocardiographic data in dogs with congestive heart failure caused by mitral valve disease and treated by multiple drugs: a retrospective study of 21 cases. de Madron E, King JN, Strehlau G, White RV. Can Vet J; 2011 Nov; 52(11):1219-25. PubMed ID: 22547843 [Abstract] [Full Text] [Related]
3. Effect of pimobendan or benazepril hydrochloride on survival times in dogs with congestive heart failure caused by naturally occurring myxomatous mitral valve disease: the QUEST study. Häggström J, Boswood A, O'Grady M, Jöns O, Smith S, Swift S, Borgarelli M, Gavaghan B, Kresken JG, Patteson M, Ablad B, Bussadori CM, Glaus T, Kovacević A, Rapp M, Santilli RA, Tidholm A, Eriksson A, Belanger MC, Deinert M, Little CJ, Kvart C, French A, Rønn-Landbo M, Wess G, Eggertsdottir AV, O'Sullivan ML, Schneider M, Lombard CW, Dukes-McEwan J, Willis R, Louvet A, DiFruscia R. J Vet Intern Med; 2008 Nov; 22(5):1124-35. PubMed ID: 18638016 [Abstract] [Full Text] [Related]
4. Efficacy of pimobendan on survival and reoccurrence of pulmonary edema in canine congestive heart failure. Mizuno M, Yamano S, Chimura S, Hirakawa A, Takusagawa Y, Sawada T, Maetani S, Takahashi A, Mizuno T, Harada K, Shinoda A, Uchida S, Takeuchi J, Mizukoshi T, Endo M, Uechi M. J Vet Med Sci; 2017 Jan 20; 79(1):29-34. PubMed ID: 27644192 [Abstract] [Full Text] [Related]
5. Lack of efficacy of low-dose spironolactone as adjunct treatment to conventional congestive heart failure treatment in dogs. Schuller S, Van Israël N, Vanbelle S, Clercx C, McEntee K. J Vet Pharmacol Ther; 2011 Aug 20; 34(4):322-31. PubMed ID: 20950346 [Abstract] [Full Text] [Related]
6. Effect of Pimobendan in Dogs with Preclinical Myxomatous Mitral Valve Disease and Cardiomegaly: The EPIC Study-A Randomized Clinical Trial. Boswood A, Häggström J, Gordon SG, Wess G, Stepien RL, Oyama MA, Keene BW, Bonagura J, MacDonald KA, Patteson M, Smith S, Fox PR, Sanderson K, Woolley R, Szatmári V, Menaut P, Church WM, O'Sullivan ML, Jaudon JP, Kresken JG, Rush J, Barrett KA, Rosenthal SL, Saunders AB, Ljungvall I, Deinert M, Bomassi E, Estrada AH, Fernandez Del Palacio MJ, Moise NS, Abbott JA, Fujii Y, Spier A, Luethy MW, Santilli RA, Uechi M, Tidholm A, Watson P. J Vet Intern Med; 2016 Nov 20; 30(6):1765-1779. PubMed ID: 27678080 [Abstract] [Full Text] [Related]
7. Efficacy of adding ramipril (VAsotop) to the combination of furosemide (Lasix) and pimobendan (VEtmedin) in dogs with mitral valve degeneration: The VALVE trial. Wess G, Kresken JG, Wendt R, Gaugele J, Killich M, Keller L, Simak J, Holler P, Bauer A, Küchenhof H, Glaus T. J Vet Intern Med; 2020 Nov 20; 34(6):2232-2241. PubMed ID: 32945575 [Abstract] [Full Text] [Related]
8. Efficacy and safet of pimobendan in canine heart failure caused by myxomatous mitral valve disease. Smith PJ, French AT, Van Israël N, Smith SG, Swift ST, Lee AJ, Corcoran BM, Dukes-McEwan J. J Small Anim Pract; 2005 Mar 20; 46(3):121-30. PubMed ID: 15789807 [Abstract] [Full Text] [Related]
9. Effects of enalapril maleate on survival of dogs with naturally acquired heart failure. The Long-Term Investigation of Veterinary Enalapril (LIVE) Study Group. Ettinger SJ, Benitz AM, Ericsson GF, Cifelli S, Jernigan AD, Longhofer SL, Trimboli W, Hanson PD. J Am Vet Med Assoc; 1998 Dec 01; 213(11):1573-7. PubMed ID: 9838955 [Abstract] [Full Text] [Related]
10. Effect of pimobendan on case fatality rate in Doberman Pinschers with congestive heart failure caused by dilated cardiomyopathy. O'Grady MR, Minors SL, O'Sullivan ML, Horne R. J Vet Intern Med; 2008 Dec 01; 22(4):897-904. PubMed ID: 18537880 [Abstract] [Full Text] [Related]
11. Pimobendan in heart failure therapy--a silver bullet? Gordon SG, Miller MW, Saunders AB. J Am Anim Hosp Assoc; 2006 Dec 01; 42(2):90-3. PubMed ID: 16527909 [Abstract] [Full Text] [Related]
12. Multiple retrospective analysis of survival and evaluation of cardiac death predictors in a population of dogs affected by degenerative mitral valve disease in ACVIM class C treated with different therapeutic protocols. Bagardi M, Locatelli C, Zanaboni A, Galizzi A, Malchiodi D, Brambilla PG. Pol J Vet Sci; 2021 Mar 01; 24(1):109-118. PubMed ID: 33847106 [Abstract] [Full Text] [Related]
13. Short-term hemodynamic and neuroendocrine effects of pimobendan and benazapril in dogs with myxomatous mitral valve disease and congestive heart failure. Häggström J, Lord PF, Höglund K, Ljungvall I, Jöns O, Kvart C, Hansson K. J Vet Intern Med; 2013 Mar 01; 27(6):1452-62. PubMed ID: 24128373 [Abstract] [Full Text] [Related]
14. Effect of prespecified therapy escalation on plasma NT-proBNP concentrations in dogs with stable congestive heart failure due to myxomatous mitral valve disease. Hezzell MJ, Block CL, Laughlin DS, Oyama MA. J Vet Intern Med; 2018 Sep 01; 32(5):1509-1516. PubMed ID: 30216549 [Abstract] [Full Text] [Related]
15. Effect of torsemide and furosemide on clinical, laboratory, radiographic and quality of life variables in dogs with heart failure secondary to mitral valve disease. Peddle GD, Singletary GE, Reynolds CA, Trafny DJ, Machen MC, Oyama MA. J Vet Cardiol; 2012 Mar 01; 14(1):253-9. PubMed ID: 22364690 [Abstract] [Full Text] [Related]
16. Safety of spironolactone in dogs with chronic heart failure because of degenerative valvular disease: a population-based, longitudinal study. Lefebvre HP, Ollivier E, Atkins CE, Combes B, Concordet D, Kaltsatos V, Baduel L. J Vet Intern Med; 2013 Mar 01; 27(5):1083-91. PubMed ID: 23869534 [Abstract] [Full Text] [Related]
17. Clinical efficacy of pimobendan versus benazepril for the treatment of acquired atrioventricular valvular disease in dogs. Lombard CW, Jöns O, Bussadori CM. J Am Anim Hosp Assoc; 2006 Mar 01; 42(4):249-61. PubMed ID: 16822763 [Abstract] [Full Text] [Related]
18. Longitudinal Analysis of Quality of Life, Clinical, Radiographic, Echocardiographic, and Laboratory Variables in Dogs with Preclinical Myxomatous Mitral Valve Disease Receiving Pimobendan or Placebo: The EPIC Study. Boswood A, Gordon SG, Häggström J, Wess G, Stepien RL, Oyama MA, Keene BW, Bonagura J, MacDonald KA, Patteson M, Smith S, Fox PR, Sanderson K, Woolley R, Szatmári V, Menaut P, Church WM, O'Sullivan ML, Jaudon JP, Kresken JG, Rush J, Barrett KA, Rosenthal SL, Saunders AB, Ljungvall I, Deinert M, Bomassi E, Estrada AH, Fernandez Del Palacio MJ, Moise NS, Abbott JA, Fujii Y, Spier A, Luethy MW, Santilli RA, Uechi M, Tidholm A, Schummer C, Watson P. J Vet Intern Med; 2018 Jan 01; 32(1):72-85. PubMed ID: 29214723 [Abstract] [Full Text] [Related]
19. Longitudinal analysis of quality of life, clinical, radiographic, echocardiographic, and laboratory variables in dogs with myxomatous mitral valve disease receiving pimobendan or benazepril: the QUEST study. Häggström J, Boswood A, O'Grady M, Jöns O, Smith S, Swift S, Borgarelli M, Gavaghan B, Kresken JG, Patteson M, Åblad B, Bussadori CM, Glaus T, Kovačević A, Rapp M, Santilli RA, Tidholm A, Eriksson A, Belanger MC, Deinert M, Little CJ, Kvart C, French A, Rønn-Landbo M, Wess G, Eggertsdottir A, Lynne O'Sullivan M, Schneider M, Lombard CW, Dukes-McEwan J, Willis R, Louvet A, DiFruscia R. J Vet Intern Med; 2013 Jan 01; 27(6):1441-51. PubMed ID: 24010489 [Abstract] [Full Text] [Related]
20. A QUEST begins. Oyama MA. J Vet Intern Med; 2008 Jan 01; 22(5):1076-8. PubMed ID: 18844829 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]